Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $29.5B |
| FY2017, ended Dec 31, 2017 | $34.1B |
| FY2018, ended Dec 31, 2018 | $49.0B |
| FY2019, ended Dec 31, 2019 | $63.1B |
| FY2020, ended Dec 31, 2020 | $50.9B |
| FY2021, ended Dec 31, 2021 | $60.6B |
| FY2022, ended Dec 31, 2022 | $66.4B |
| FY2023, ended Dec 31, 2023 | $84.8B |
| FY2024, ended Dec 31, 2024 | $132B |
| FY2025, ended Dec 31, 2025 | $141B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $61.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.08B |
| FY2017, ended Dec 31, 2017 | $9.05B |
| FY2018, ended Dec 31, 2018 | $9.82B |
| FY2019, ended Dec 31, 2019 | $10.7B |
| FY2020, ended Dec 31, 2020 | $9.91B |
| FY2021, ended Dec 31, 2021 | $11.9B |
| FY2022, ended Dec 31, 2022 | $12.7B |
| FY2023, ended Dec 31, 2023 | $14.2B |
| FY2024, ended Dec 31, 2024 | $16.7B |
| FY2025, ended Dec 31, 2025 | $20.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $347M | $806M |
| FY2017, ended Dec 31, 2017 | $104M | $1.11B |
| FY2018, ended Dec 31, 2018 | $1.67B | −$6.00M |
| FY2019, ended Dec 31, 2019 | $4.70B | $1.38B |
| FY2020, ended Dec 31, 2020 | −$115M | $1.13B |
| FY2021, ended Dec 31, 2021 | $985M | $1.32B |
| FY2022, ended Dec 31, 2022 | $642M | $938M |
| FY2023, ended Dec 31, 2023 | $1.57B | $1.79B |
| FY2024, ended Dec 31, 2024 | $1.85B | $2.65B |
| FY2025, ended Dec 31, 2025 | $2.90B | $3.66B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.67B | $3.63B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $196M |
| FY2017, ended Dec 31, 2017 | $188M |
| FY2018, ended Dec 31, 2018 | $146M |
| FY2019, ended Dec 31, 2019 | $217M |
| FY2020, ended Dec 31, 2020 | $1.73B |
| FY2021, ended Dec 31, 2021 | $1.93B |
| FY2022, ended Dec 31, 2022 | $928M |
| FY2023, ended Dec 31, 2023 | $865M |
| FY2024, ended Dec 31, 2024 | $414M |
| FY2025, ended Dec 31, 2025 | $1.97B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $539M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.42B |
| FY2017, ended Dec 31, 2017 | $3.81B |
| FY2018, ended Dec 31, 2018 | $7.06B |
| FY2019, ended Dec 31, 2019 | $10.0B |
| FY2020, ended Dec 31, 2020 | $9.14B |
| FY2021, ended Dec 31, 2021 | $9.06B |
| FY2022, ended Dec 31, 2022 | $8.94B |
| FY2023, ended Dec 31, 2023 | $9.10B |
| FY2024, ended Dec 31, 2024 | $10.7B |
| FY2025, ended Dec 31, 2025 | $11.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 6.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.36B |
| FY2017, ended Dec 31, 2017 | 1.37B |
| FY2018, ended Dec 31, 2018 | 1.39B |
| FY2019, ended Dec 31, 2019 | 1.40B |
| FY2020, ended Dec 31, 2020 | 1.42B |
| FY2021, ended Dec 31, 2021 | 1.43B |
| FY2022, ended Dec 31, 2022 | 1.43B |
| FY2023, ended Dec 31, 2023 | 1.47B |
| FY2024, ended Dec 31, 2024 | 1.48B |
| FY2025, ended Dec 31, 2025 | 1.48B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.45B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $116M | $111M |
| FY2017, ended Dec 31, 2017 | — | $127M | $85.0M |
| FY2018, ended Dec 31, 2018 | $0 | $140M | $0 |
| FY2019, ended Dec 31, 2019 | $0 | $157M | $0 |
| FY2020, ended Dec 31, 2020 | $535M | $170M | $975M |
| FY2021, ended Dec 31, 2021 | $0 | $194M | $0 |
| FY2022, ended Dec 31, 2022 | $0 | $220M | $0 |
| FY2023, ended Dec 31, 2023 | — | $233M | — |
| FY2024, ended Dec 31, 2024 | — | $266M | — |
| FY2025, ended Dec 31, 2025 | — | $299M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $320M | — |
Valuation
At current price- Market Cap
- $65.3B
- P/E
- 17.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.1×
- Price / Book
- 2.6×
- EV / EBITDA
- 13.9×
Growth
Trailing 12 months- Revenue (TTM)
- $21.0B
- Revenue Growth YoY
- 13.5%
- Revenue CAGR 3Y
- 16.5%
- Revenue CAGR 5Y
- 15.2%
- EPS Growth YoY
- 47.0%
- Net Income Growth YoY
- 46.7%
Profitability
Trailing 12 months- Gross Margin
- 69.9%
- Operating Margin
- 19.8%
- Net Margin
- 17.5%
- FCF Margin
- 17.3%
- Return on Equity
- 15.5%
Earnings
Trailing 12 months- Net Income
- $3.67B
- EPS (diluted)
- $2.47
- EBITDA
- $5.57B
- Operating Income
- $4.15B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $539M
- Total Debt
- $12.6B
- Net Debt
- $12.1B
- Total Assets
- $45.2B
- Total Liabilities
- $20.0B
- Shareholders' Equity
- $24.9B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.53B
- Capital Expenditure
- $904M
- Free Cash Flow
- $3.63B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.58
Every ratio is calculated from the company’s reported figures.